CN108020665A - Set group and sampling gimmick are tested in upper and lower digestive system cancer screening - Google Patents
Set group and sampling gimmick are tested in upper and lower digestive system cancer screening Download PDFInfo
- Publication number
- CN108020665A CN108020665A CN201610934077.5A CN201610934077A CN108020665A CN 108020665 A CN108020665 A CN 108020665A CN 201610934077 A CN201610934077 A CN 201610934077A CN 108020665 A CN108020665 A CN 108020665A
- Authority
- CN
- China
- Prior art keywords
- sample
- groove
- antibody
- control zone
- fruiting area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
Abstract
Set group is tested in a kind of digestive system cancer screening up and down, includes a corpse or other object for laboratory examination and chemical testing bottle, a checkbox, and a sample solution.The checkbox is provided with the antibody that can be combined with the occult blood in excrement and helicobacter pylori and colloidal gold composite, and including a sample slot unit, and an inspection groove unit.The inspection groove unit has first fruiting area, second fruiting area, and at least one control zone.First fruiting area has the first antibody that can be combined with helicobacter pylori.Second fruiting area has the secondary antibody that can be combined with occult blood.The control zone has the control antibody that can be combined with the antibody with colloidal gold composite.The pH value of the sample solution is 8.0, and be 10mM including concentration trishydroxymethylaminomethane hydrochloride, concentration be 0.05wt% sodium azide, and for pH value to be adjusted to 8.0 sodium hydroxide.User only needs sampling once and drips to survey once obtain two kinds of inspection results at the same time, and detection is quite convenient.
Description
Technical field
The present invention relates to a kind of vitro detection reagent object, more particularly to a kind of digestive system cancer screening up and down test set group and
Sample gimmick.
Background technology
The digestive system of human body has the organs such as esophagus, Stomach duodenum, small intestine, large intestine, anus.Wherein, esophagus, stomach, ten
Two duodenum 12 are classified as upper digestive tract, and large intestine is then classified as lower digestive tract with anus.The common disease of upper digestive tract is stomach
And duodenum infection helicobacter pylori and thus chronic inflammation, ulcer or carninomatosis change.The common disease of lower digestive tract is then
Large intestine produces polyp, diverticulum and colorectal cancer etc..When upper digestive tract is by Helicobacter pylori infection, the excrement of patient will band
There is helicobacter pylori, and when lower digestive tract produces lesion, the excrement of patient can then carry a small amount of blood, that is to say, that be commonly called as
Fecal occult blood.Therefore, examine in excrement whether contain helicobacter pylori and occult blood, that is, will appreciate that the upper digestive tract of subject
Whether have potential dangerous with lower digestive tract and need to further go through.
Refering to Fig. 1, existing it is used to examine in excrement whether the upper digestive tract containing helicobacter pylori to be examined to be a kind of
Group 1, and it is a kind of it is existing be used to examining in excrement whether the lower digestive tract check groups 2 containing occult blood.The upper digestive tract is examined
Group 1 has first corpse or other object for laboratory examination and chemical testing bottle 11, a the first sample solution 12 being housed in first corpse or other object for laboratory examination and chemical testing bottle 11, and one is used for
Represent the first checkbox 13 of inspection result.First checkbox 13 is provided with the antibody and glue that can be combined with helicobacter pylori
Body Au composite, and there is the first sample groove 131 of confession first sample solution 12 instillation, and one can represent to examine knot
The first of fruit examines groove 132.The first inspection groove 132 has first fruiting area 133, and first control zone 134.
First fruiting area 133 is provided with helicobacter pylori resistant antigen-antibody.First control zone 134 be provided with can with the antibody with
The control antibody that colloidal gold composite combines.
The lower digestive tract check groups 2 have second corpse or other object for laboratory examination and chemical testing bottle 21, it is a be housed in second corpse or other object for laboratory examination and chemical testing bottle 21 the
Two sample solutions 22, and second checkbox 23 for being used to represent inspection result.Second checkbox 23 is provided with energy and excrement
Just the antibody and colloidal gold composite that the occult blood in combines, and with the second sample slot of confession second sample solution 22 instillation
231, and a second inspection groove 232 that can represent inspection result.The second inspection groove 232 has second fruiting area
233, and second control zone 234.Second fruiting area 233 is provided with anti-hematin antibodies.Second control zone 234 is set
It is equipped with the control antibody that can be combined with the antibody with colloidal gold composite.
The upper digestive tract check groups 1 are to take excrement, and the excrement that will be dug first with first corpse or other object for laboratory examination and chemical testing bottle 11 when in use
Just insert in first sample solution 12, then first sample solution 12 for being mixed with excrement is instilled in the first sample groove 131.This
One sample solution 12 can be moved to by the first sample groove 131 in the first inspection groove 132, and successively passes through first fruiting area
133 with first control zone 134.Combined as carried helicobacter pylori in excrement with the antibody with colloidal gold composite, then
First fruiting area 133 can form a colo(u)r streak respectively with first control zone 134, as having no helicobacter pylori in excrement,
Then only it can form a colo(u)r streak in first control zone 134.The occupation mode of the lower digestive tract check groups 2 is with interpretation method with being somebody's turn to do
The occupation mode of upper digestive tract check groups 1 is similar with interpretation method, not repeat specification.
Though the upper digestive tract check groups 1 can be operated independently with the lower digestive tract check groups 2, fortune can not be interacted
Make.For example, first sample solution 12 for being mixed with excrement is dropped in second sample slot 231 of second checkbox 23,
Even if carrying occult blood in the excrement of subject, a colo(u)r streak can not be also formed on second fruiting area 233.Similarly, will be mixed
Second sample solution 22 for having excrement is dropped on the first sample groove 131 of first checkbox 13, even if the excrement of subject
In carry helicobacter pylori, a colo(u)r streak can not be also formed on first fruiting area 133.That is, first sampling
Liquid 12 is only applicable to the detection of helicobacter pylori, which is only applicable to fecal occult blood detection, both can not lead to
With, it certainly will must all prepare two kinds of sample solutions in each detection, it is quite inconvenient and to be improved.
The content of the invention
The first object of the present invention is that providing a kind of digestive system cancer screening up and down tests set group, can solve background technology extremely
A few problem.
Set group is tested in digestive system cancer screening up and down of the invention, includes a corpse or other object for laboratory examination and chemical testing bottle, a checkbox, and a sampling
Liquid, which is provided with the antibody that can be combined with the occult blood in excrement and helicobacter pylori and colloidal gold composite, and wraps
The sample slot unit that the confession sampling drop is put, and an inspection groove unit are included, which has at least one
Control zone, the inspection groove unit also have first fruiting area being entered respectively for the sample solution by the sample slot unit and
One the second fruiting area, first fruiting area have the first antibody that can be combined with helicobacter pylori, second fruiting area tool
There is the secondary antibody that can be combined with occult blood, which has the control antibody that energy and the antibody are combined with colloidal gold composite,
The sampling liquid energy allows the antibody to be combined with colloidal gold composite with the occult blood in excrement and helicobacter pylori, and the sample solution
PH value is 8.0, and be 10mM including concentration trishydroxymethylaminomethane hydrochloride, concentration be 0.05wt% Azide
Sodium, and for pH value to be adjusted to 8.0 sodium hydroxide.
It is of the present invention up and down digestive system cancer screening test set group, the sample slot unit have each other between left and right every one
First sample groove and second sample slot, the inspection groove unit have respectively can for sample solution entrance a correspondence this
The first of one sample slot examines the second of groove second sample slot corresponding with one to examine groove, and the control zone of two,
This first examines groove to have the control zone with one of them of first sample groove separately, and be located in one of should
First fruiting area between control zone and the first sample groove, this second examines groove to have and second sample slot separately another
Second fruiting area between one control zone, and the control zone positioned at another and second sample slot.
Set group is tested in digestive system cancer screening up and down of the present invention, which has a first sample groove, should
Examine groove unit that there is one first inspection groove, which has the control zone with the first sample groove separately,
And first fruiting area between the control zone and the first sample groove and second fruiting area.
The sampling liquid energy of the present invention allows the antibody and colloidal gold composite and the occult blood and helicobacter pylori in excrement
With reference to, pH value 8.0, and including contributing to the component of detection, two antigens in a corpse or other object for laboratory examination and chemical testing can be allowed to be detected as each adaptive at the same time
With the efficiency as sample solution.
The beneficial effects of the present invention are：The sample solution special component can allow in the antibody and colloidal gold composite and excrement
Occult blood combined with helicobacter pylori, and the sample solution do not interfere with the antibody and colloidal gold composite and the first antibody and
The secondary antibody combines, therefore can form a color that can be substantially observed respectively in first fruiting area and second fruiting area
Line, and test effect can be produced.
Another object of the present invention is to provide a kind of sieve of digestive system cancer up and down sampling gimmick, there is the excellent of simple flow
Point.
The sieve of digestive system cancer up and down sampling gimmick of the present invention, suitable for above-described digestive system cancer screening up and down of arranging in pairs or groups
The use of set group is tested, which includes：Step A：Excrement is put into the sample solution, step B：Will be through
The sample solution of processing of step A is instilled in the sample slot unit, and step C：Observe first fruiting area, second fruiting area
With the control zone, and inspection result is obtained.
The beneficial effects of the present invention are：Only excrement is put into the sample solution once and dripped and is put once, there is flow letter
Just the advantages of.
Brief description of the drawings
The other features and effect of the present invention, will clearly be presented in the embodiment with reference to schema, wherein：
Fig. 1 is a stereogram of an existing upper digestive tract check groups and a lower digestive tract check groups；
Fig. 2 is a stereogram of the first embodiment that set group is tested in digestive system cancer screening above and below the present invention；
Fig. 3 is a process for using figure of the first embodiment；
Fig. 4 is the explanation schematic diagram of a possible testing result of the first embodiment；
Fig. 5 is an experimental result integration map of the first embodiment；
Fig. 6 is that an experimental result of first comparative example that set group is tested in digestive system cancer screening above and below the present invention is integrated
Figure；
Fig. 7 is that an experimental result of second comparative example that set group is tested in digestive system cancer screening above and below the present invention is integrated
Figure；
Fig. 8 be the present invention up and down digestive system cancer screening test set group a second embodiment a stereogram and
Fig. 9 is the colour atla that each embodiment of present invention collocation is used with each comparative example.
Embodiment
Before the present invention is described in detail, it shall be noted that in the following description content, similar element is with identical
Number to represent.
Refering to Fig. 2, Fig. 3 and Fig. 4, a first embodiment of set group is tested in digestive system cancer screening up and down of the invention, includes one
A 3, checkboxs 4 of corpse or other object for laboratory examination and chemical testing bottle, and a sample solution 5 being housed among the corpse or other object for laboratory examination and chemical testing bottle 3.
The corpse or other object for laboratory examination and chemical testing bottle 3, which includes a body 31, one, can open the bottle cap 32 that ground lid is located on the body 31, and one
The bottle brush 33 down extended by the bottle cap 32.The bottle cap 32 has a lid 321 that liquid can be allowed to flow out, and an energy is beaten
Turn up the soil the headkerchief 322 being arranged on the lid 321.The bottle brush 33 is in hollow columnar, and is plugged into the sample solution 5, can allow this
Sample solution 5 among itself by the lid 321 through being flowed out.
The checkbox 4 is provided with can be compound with the antibody that the occult blood in excrement and helicobacter pylori are combined and colloidal gold
Thing, and the sample slot unit 41 put including the confession sample solution 5 drop, and an inspection groove unit 42.The sample slot unit
41 have each other between left and right every a first sample groove 411 and second sample slot 412.The inspection groove unit 42, which has, to be divided
First inspection second sample corresponding with one of groove 421 for the correspondence first sample groove 411 that the sample solution 5 enters can be supplied
The second of this groove 412 examines groove 422.The first inspection groove 421 has one and the control zone of first sample groove 411 separately
C, and a first fruiting area R1 between control zone C and the first sample groove 411.First fruiting area R1 has energy
The first antibody combined with helicobacter pylori.The first antibody is helicobacter pylori resistant antigen-antibody.The second inspection groove
422 have another control zone C with second sample slot 412 separately, and one positioned at another control zone C with
The second fruiting area R2 between second sample slot 412.Second fruiting area R2 has the secondary antibody that can be combined with occult blood.This
Two antibody are anti-hematin antibodies.There is the control zone C control that can be combined with the antibody with colloidal gold composite to resist respectively
Body.The antibody and colloidal gold composite can be arranged on the first sample groove 411 and this first examine groove 421 between, and this second
Sample slot 412 and this second examine groove 422 between, for the sample solution 5 first contact the antibody and colloidal gold composite enter back into this
One examines in groove 421 and the second inspection groove 422.
The sample solution 5 includes the trishydroxymethylaminomethane hydrochloride (Tris (hydroxymethyl) that concentration is 10mM
Aminomethane Hydrochloride, Tris-Hydrochloride), concentration be 0.05wt% sodium azide
(NaN3), and for pH value to be adjusted to 8.0 sodium hydroxide.The sample solution 5 be beneficial to the antibody and colloidal gold composite with
Occult blood in excrement and helicobacter pylori combine, and can allow two antigens (ferroheme and helicobacter pylori) in a corpse or other object for laboratory examination and chemical testing tested at the same time
Survey the efficiency as in each self application sample solution.
Refering to Fig. 3, Fig. 4 and Fig. 5, the application method of this first embodiment is as follows：The bottle cap 32 is opened, and utilizes the bottle brush
33 pick a small amount of excrement to be measured, which is turned back among the body 31 together with the excrement picked, makes picked excrement
Just immerse in the sample solution 5.Then after the sample solution 5 is shaken up, the headkerchief 322 of the bottle cap 32 is opened, and by the sample solution 5
Dripped by the corpse or other object for laboratory examination and chemical testing bottle 3 into the first sample groove 411 of the sample slot unit 41 and second sample slot 412.Wait for quietly 10 minutes
Afterwards, such as control zone C cannot form a colo(u)r streak, then this first embodiment belongs to improper running, and such as the control zone C can shape
Into a colo(u)r streak, then this first embodiment category normal operation, observing the first fruiting area R1 and second fruiting area R2 may produce
Raw four kinds of results as shown in Figure 4.(A) in Fig. 4 represents have occult blood and helicobacter pylori at the same time in patient's excrement.Fig. 4
In (B) represent there is helicobacter pylori in patient's excrement but do not have occult blood.(C) in Fig. 4 represents to deposit in patient's excrement
There is occult blood but do not have helicobacter pylori.(D) in Fig. 4 is represented in patient's excrement both without helicobacter pylori, also without occult blood.
Refering to Fig. 5.(A) in Fig. 5 is inspection result of this first embodiment for the excrement of no helicobacter pylori, in
A colo(u)r streak will not be formed in the R1 of first fruiting area.(B) in Fig. 5 is used for having helicobacter pylori for this first embodiment
The inspection result of excrement, forms the colo(u)r streak that a chromaticity evaluation is 25 to 30 in the R1 of first fruiting area.(C) in Fig. 5 is
Inspection result of this first embodiment for the excrement of no occult blood, a colo(u)r streak will not be formed in the R2 of second fruiting area.Fig. 5
In (D) be this first embodiment be used for have occult blood excrement inspection result, in the R2 of second fruiting area formed a color
Degree is evaluated as 7 to 8 colo(u)r streak.
Refering to Fig. 6, of the invention one existing be used to detecting in excrement whether the first ratio containing helicobacter pylori
Similar with the first embodiment compared with example, different places is that the composition of the sample solution 5 is different., should in this first comparative example
Sample solution 5 include concentration be 40mM trishydroxymethylaminomethane (Tris (hydroxymethyl) aminomethane,
Tris), concentration is the bovine serum albumin(BSA) (BSA) of 0.1wt%, and for pH value to be adjusted to 7.6 hydrochloric acid.In Fig. 6
(A), in the inspection result of the excrement of no helicobacter pylori, will not be formed in the R1 of first fruiting area for originally first comparative example
One colo(u)r streak.(B) in Fig. 6 is the inspection result that this first comparative example is used to have the excrement of helicobacter pylori, in this first
The colo(u)r streak of chromaticity evaluation 25 to 30 is formed in the R1 of fruiting area.(C) in Fig. 6 is this first comparative example for the excrement of no occult blood
Inspection result, a colo(u)r streak will not be formed in the R2 of second fruiting area.(D) in Fig. 6 is used to have latent for this first comparative example
The inspection result of the excrement of blood, can not form a colo(u)r streak in the R2 of second fruiting area, or to form a chromaticity evaluation small
The colo(u)r streak that recognizes is not easy in 3.
Refering to Fig. 7, of the invention one existing be used to detecting in excrement whether the second comparative example containing occult blood, with this
First embodiment is similar, and different places is that the composition of the sample solution 5 is different.In this second comparative example, which wraps
Including potassium dihydrogen phosphate, concentration that potassium chloride, concentration that sodium chloride, concentration that concentration is 136.89mM are 2.68mM are 1.76mM is
The disodium hydrogen phosphate of 10.16mM, and for pH value to be adjusted to 7.6 hydrochloric acid.(A) in Fig. 7 for this second comparative example in
The inspection result of excrement without helicobacter pylori, a colo(u)r streak will not be formed in the R1 of first fruiting area.(B) in Fig. 7
It is used for the inspection result of excrement for having helicobacter pylori for this second comparative example, one is can be only formed in the R1 of first fruiting area
Bar chromaticity evaluation is less than 3 and is not easy the colo(u)r streak recognized.(C) in Fig. 7 is inspection of this second comparative example for the excrement of no occult blood
Test as a result, a colo(u)r streak will not be formed in the R2 of second fruiting area.(D) is used for having occult blood for this second comparative example in Fig. 7
The inspection result of excrement, forms the colo(u)r streak of a chromaticity evaluation 6 to 7 in the R2 of second fruiting area.
The experimental result of Fig. 5 to Fig. 7 shows that the first comparative example and the second comparative example of existing formula, can only be useful in
Original predetermined detection species, when being used in non-original predetermined detection species, should provide the occasion of positive judgement, can be because
Cognizable colo(u)r streak can not be presented, and can not correctly provide the inspection result of positive reaction.On the contrary, the first embodiment energy
Two kinds of targets are detected at the same time, that is to say, that, all can be in this when detection is respectively containing occult blood with there is the excrement of helicobacter pylori
First fruiting area R1 and second fruiting area R2 produces the cognizable colo(u)r streak of naked eyes, allows user to learn exactly strictly positive
Reaction, reaches the purpose of inspection.
In conclusion set group is tested in digestive system cancer screening to the present invention up and down and the sample solution 5 of sampling gimmick includes three hydroxyl
Aminomethane hydrochloride, and pH value is 8.0, can allow occult blood and pylorus in the antibody and colloidal gold composite and excrement
Pylori combines, and the sample solution does not interfere with the antibody and colloidal gold composite and the first antibody and the secondary antibody knot
Close, therefore a colo(u)r streak that can be substantially observed can be formed respectively in first fruiting area and second fruiting area, and can be normal
Ground produces expected inspection result at the same time, therefore the present invention can allow two antigens in a corpse or other object for laboratory examination and chemical testing to be detected as sampled in each self application at the same time
Efficiency as liquid.In addition, in the use of the present invention, only need excrement being put into sample solution once, without multi-pass operation, therefore use
The gimmick that the present invention samples is quite easy.
Refering to Fig. 8, of the invention second embodiment is similar with first implementation of class, and different places is sheet second
The sample slot unit 41 of embodiment only includes the first sample groove 411, and the inspection groove unit 42 is only comprising the first inspection groove
421.The first inspection groove 421 includes the control zone C with the first sample groove 411 separately.First fruiting area R1 is located at
Between control zone C and the first sample groove 411.Second fruiting area R2 is between the first fruiting area R1 and control zone C.This
Two embodiments are advantageous in that the volume that can reduce the checkbox 4.
Claims (4)
- , should comprising a corpse or other object for laboratory examination and chemical testing bottle, a checkbox, and a sample solution 1. set group is tested in a kind of digestive system cancer screening up and down Checkbox is provided with the antibody that can be combined with the occult blood in excrement and helicobacter pylori and colloidal gold composite, and including one The sample slot unit put for the sampling drop, and an inspection groove unit, the inspection groove unit have at least one control zone, It is characterized in that：The inspection groove unit also has first result that the sample solution can be supplied to be entered by the sample slot unit respectively Area and second fruiting area, first fruiting area have the first antibody that can be combined with helicobacter pylori, second result Area has the secondary antibody that can be combined with occult blood, and the control which there is energy and the antibody to be combined with colloidal gold composite resists Body, which allows the antibody to be combined with colloidal gold composite with the occult blood in excrement and helicobacter pylori, and the sampling The pH value of liquid be 8.0, and be 10mM including concentration trishydroxymethylaminomethane hydrochloride, concentration be 0.05wt% nitrine Change sodium, and for pH value to be adjusted to 8.0 sodium hydroxide.
- 2. set group is tested in digestive system cancer screening up and down according to claim 1, it is characterised in that：The sample slot unit has that This between left and right every a first sample groove and second sample slot, the inspection groove unit have respectively can for the sample solution into The first of the correspondence first sample groove entered examines the second inspection groove of groove second sample slot corresponding with one, and two A control zone, the first inspection groove have the control zone with one of them of first sample groove separately, Yi Jiwei First fruiting area between the control zone of one of them and the first sample groove, which has and second sample Between another the control zone of this groove separately, and the control zone positioned at another and second sample slot this second Fruiting area.
- 3. set group is tested in digestive system cancer screening up and down according to claim 1, it is characterised in that：The sample slot unit has one A first sample groove, the inspection groove unit have one first inspection groove, which has and the first sample groove phase The control zone at interval, and first fruiting area and second fruiting area between the control zone and the first sample groove.
- A kind of 4. sieve of digestive system cancer up and down sampling gimmick, suitable for arranging in pairs or groups according to any claim in claims 1 to 3 The use of set group is tested in upper and lower digestive system cancer screening, it is characterised in that：The upper and lower digestive system cancer sieve sampling gimmick includes：Step A：By excrement Just it is put into the sample solution, step B：The sample solution through processing of step A is instilled in the sample slot unit, and step C：See First fruiting area, second fruiting area and the control zone are examined, and obtains inspection result.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610934077.5A CN108020665A (en) | 2016-10-31 | 2016-10-31 | Set group and sampling gimmick are tested in upper and lower digestive system cancer screening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610934077.5A CN108020665A (en) | 2016-10-31 | 2016-10-31 | Set group and sampling gimmick are tested in upper and lower digestive system cancer screening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108020665A true CN108020665A (en) | 2018-05-11 |
Family
ID=62069921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610934077.5A Withdrawn CN108020665A (en) | 2016-10-31 | 2016-10-31 | Set group and sampling gimmick are tested in upper and lower digestive system cancer screening |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108020665A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020034845A1 (en) * | 2018-08-16 | 2020-02-20 | 吴智良 | Excrement occult blood detection device and method |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060188939A1 (en) * | 2005-02-16 | 2006-08-24 | Ping Gao | Fecal sample test device and methods of use |
| WO2007068310A1 (en) * | 2005-12-14 | 2007-06-21 | The Jordanian Pharmaceutical Manufacturing Co. | Device for the early and rapid immunochromatographic detection of hiv and uses thereof |
| CN101221174A (en) * | 2006-11-28 | 2008-07-16 | 自由健康有限公司 | Apparatus and methods for identification and localization of ulcers and other digestive tract bleeding in equines |
| CN101236210A (en) * | 2008-01-29 | 2008-08-06 | 王学生 | Rapid joint inspection reagent for hemoglobin -haptoglobin complex and occult blood in stool |
| US20090111194A1 (en) * | 2007-10-30 | 2009-04-30 | John Wan | Methods and device for the detection of occult blood |
| CN201477101U (en) * | 2009-06-04 | 2010-05-19 | 万华普曼生物工程有限公司 | Transferrin and hemoglobin combined detection board |
| CN102393460A (en) * | 2011-08-22 | 2012-03-28 | 万积成 | Rapid detection device for helicobacter pylori |
| CN202903803U (en) * | 2012-07-27 | 2013-04-24 | 王学生 | Kit for quick combined detection of hemoglobin-haptoglobin complex and fecal occult blood |
| CN105467124A (en) * | 2015-12-18 | 2016-04-06 | 厦门稀土材料研究所 | Colloid gold duplex test strip for detecting fecal occult blood and preparation method thereof |
-
2016
- 2016-10-31 CN CN201610934077.5A patent/CN108020665A/en not_active Withdrawn
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060188939A1 (en) * | 2005-02-16 | 2006-08-24 | Ping Gao | Fecal sample test device and methods of use |
| WO2007068310A1 (en) * | 2005-12-14 | 2007-06-21 | The Jordanian Pharmaceutical Manufacturing Co. | Device for the early and rapid immunochromatographic detection of hiv and uses thereof |
| CN101221174A (en) * | 2006-11-28 | 2008-07-16 | 自由健康有限公司 | Apparatus and methods for identification and localization of ulcers and other digestive tract bleeding in equines |
| US20090111194A1 (en) * | 2007-10-30 | 2009-04-30 | John Wan | Methods and device for the detection of occult blood |
| CN101236210A (en) * | 2008-01-29 | 2008-08-06 | 王学生 | Rapid joint inspection reagent for hemoglobin -haptoglobin complex and occult blood in stool |
| CN201477101U (en) * | 2009-06-04 | 2010-05-19 | 万华普曼生物工程有限公司 | Transferrin and hemoglobin combined detection board |
| CN102393460A (en) * | 2011-08-22 | 2012-03-28 | 万积成 | Rapid detection device for helicobacter pylori |
| CN202903803U (en) * | 2012-07-27 | 2013-04-24 | 王学生 | Kit for quick combined detection of hemoglobin-haptoglobin complex and fecal occult blood |
| CN105467124A (en) * | 2015-12-18 | 2016-04-06 | 厦门稀土材料研究所 | Colloid gold duplex test strip for detecting fecal occult blood and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020034845A1 (en) * | 2018-08-16 | 2020-02-20 | 吴智良 | Excrement occult blood detection device and method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69728158T2 (en) | IMMUNOASSAYS IN CAPILLARY TUBES | |
| JP5335802B2 (en) | Method and apparatus for detecting occult blood | |
| CN101258406A (en) | Analyzer and analyzing method | |
| CN104126120A (en) | Paper based diagnostic test | |
| CN104246502B (en) | The device of the analysis thing in fluid sample can be included in for measuring at least one | |
| CN107621539A (en) | A kind of method of analyte in detection means and detection liquid sample | |
| CN107271693A (en) | A kind of quick feces occult blood duplex inspects paper slip and preparation method thereof | |
| CN110488025A (en) | A kind of chemiluminescence quantitative detection excrement calprotectin and its detection method and its intestinal health detection purposes | |
| CN107045062A (en) | Detect colloidal gold immuno-chromatography test paper strip, kit of human neutrophil genatinase associated lipocalin and preparation method thereof | |
| CN108802360A (en) | Commutative copper and one step of ceruloplasmin are detected with kit, preparation method and application simultaneously in a kind of serum | |
| DE19920704C1 (en) | Use of an anti-urinary trypsin inhibitor antibody for the diagnosis of the onset of AIDS | |
| NO149864B (en) | IMMUNOLOGICAL REAGENT. | |
| McGrotty et al. | Disorders of plasma proteins | |
| EP3221444B1 (en) | Lateral flow assay ratio test | |
| Demiray et al. | Comparison of invasive methods and two different stool antigen tests for diagnosis of H pylori infection in patients with gastric bleeding | |
| CN108020665A (en) | Set group and sampling gimmick are tested in upper and lower digestive system cancer screening | |
| CN108291909A (en) | Analyze analyte detection and its method | |
| CN106460056A (en) | Novel method for detecting detection object in sample, and detection kit using same | |
| CN107727855A (en) | For detecting the sample pad of HIV antibody in urine, sample pad treatment fluid and test strips | |
| Väänänen et al. | Rapid immunochemical detection of fecal occult blood by use of a latex-agglutination test. | |
| CN104849455B (en) | A kind of based on Syphilis serum test protein chip preparation and application | |
| CN107271678A (en) | The diagnostic kit manufacture purposes and aided diagnosis method of development of renal disease risk | |
| CN104198692B (en) | Mixed marking substance and marking method as well as application thereof | |
| EP2623979A1 (en) | Immunochromatographic inspection method and device | |
| CN107727861B (en) | A kind of pepsin assay kit and measuring method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180511 |